Skip to main content
Clinical Trials/NCT00772356
NCT00772356CompletedNot Applicable

A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I Diabetes

Hoffmann-La Roche1 site in 1 country14 target enrollmentStarted: January 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
14
Locations
1
Primary Endpoint
Comparison of glucose infusion rate necessary to keep blood glucose constant

Study Overview

Brief Summary

This crossover, glucose-clamp study will investigate the impact of different basal insulin infusion rates on glucose control employing insulin pumps with different insulin delivery regimen. Patients will be randomized in one of 2 groups, to receive on the first study day insulin via pumps with pulsatile or quasi-continuous delivery modes. On the second study day they will be switched to treatment with the alternative delivery regimen. The anticipated duration of the trial is 2 study days and the target sample size is 14 individuals.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male patients 18-65 years of age
  • •Type I diabetes mellitus
  • •Currently on continuous subcutaneous insulin infusion therapy

Exclusion Criteria

  • •Proliferative retinopathy or maculopathy requiring actue treatment within last 6 months
  • •Use of systemic corticoids in last 3 months
  • •Treatment with medication known to interfere with glucose metabolism

Arms & Interventions

A

Experimental

Intervention: Accu-Chek Spirit Insulin Pump (Device)

B

Active Comparator

Intervention: Comparator insulin pump (Device)

Outcomes

Primary Outcomes

Comparison of glucose infusion rate necessary to keep blood glucose constant

Time Frame: Throughout study

Secondary Outcomes

  • Serum insulin and free fatty acid levels(Throughout study)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials